
### [Orphanet:104013](http://www.orpha.net/ORDO/Orphanet_104013)
**Label:** Metabolic disease with intestinal involvement

**Subclasses:** [Orphanet:298](http://www.orpha.net/ORDO/Orphanet_298) (Mitochondrial neurogastrointestinal encephalomyopathy), [Orphanet:254803](http://www.orpha.net/ORDO/Orphanet_254803) (Mitochondrial DNA depletion syndrome, encephalomyopathic form), [Orphanet:699](http://www.orpha.net/ORDO/Orphanet_699) (Pearson syndrome), 

**Corr. equiv. classes:** [Orphanet:298](http://www.orpha.net/ORDO/Orphanet_298), [OMIM:613662](http://purl.obolibrary.org/obo/OMIM_613662), [OMIM:557000](http://purl.obolibrary.org/obo/OMIM_557000), [OMIM:612073](http://purl.obolibrary.org/obo/OMIM_612073), [OMIM:612075](http://purl.obolibrary.org/obo/OMIM_612075), [Orphanet:254803](http://www.orpha.net/ORDO/Orphanet_254803), [Orphanet:699](http://www.orpha.net/ORDO/Orphanet_699), [OMIM:603041](http://purl.obolibrary.org/obo/OMIM_603041), 

**Class expressions from DL-Learner:**

- [HP:0100651](http://purl.obolibrary.org/obo/HP_0100651) (Type I diabetes mellitus) and [HP:0100732](http://purl.obolibrary.org/obo/HP_0100732) (Pancreatic fibrosis) 62.50%
- [HP:0011014](http://purl.obolibrary.org/obo/HP_0011014) (Abnormal glucose homeostasis) and [HP:0100732](http://purl.obolibrary.org/obo/HP_0100732) (Pancreatic fibrosis) 62.50%
- [HP:0011013](http://purl.obolibrary.org/obo/HP_0011013) (Abnormality of carbohydrate metabolism/homeostasis) and [HP:0100732](http://purl.obolibrary.org/obo/HP_0100732) (Pancreatic fibrosis) 62.50%
- [HP:0004360](http://purl.obolibrary.org/obo/HP_0004360) (Abnormality of acid-base homeostasis) and [HP:0100732](http://purl.obolibrary.org/obo/HP_0100732) (Pancreatic fibrosis) 62.50%
- [HP:0003128](http://purl.obolibrary.org/obo/HP_0003128) (Lactic acidosis) and [HP:0100732](http://purl.obolibrary.org/obo/HP_0100732) (Pancreatic fibrosis) 62.50%
- [HP:0001942](http://purl.obolibrary.org/obo/HP_0001942) (Metabolic acidosis) and [HP:0100732](http://purl.obolibrary.org/obo/HP_0100732) (Pancreatic fibrosis) 62.50%
- [HP:0001941](http://purl.obolibrary.org/obo/HP_0001941) (Acidosis) and [HP:0100732](http://purl.obolibrary.org/obo/HP_0100732) (Pancreatic fibrosis) 62.50%
- [HP:0001903](http://purl.obolibrary.org/obo/HP_0001903) (Anemia) and [HP:0100732](http://purl.obolibrary.org/obo/HP_0100732) (Pancreatic fibrosis) 62.50%
- [HP:0001877](http://purl.obolibrary.org/obo/HP_0001877) (Abnormality of erythrocytes) and [HP:0100732](http://purl.obolibrary.org/obo/HP_0100732) (Pancreatic fibrosis) 62.50%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) and [HP:0100732](http://purl.obolibrary.org/obo/HP_0100732) (Pancreatic fibrosis) 62.50%
- [HP:0000819](http://purl.obolibrary.org/obo/HP_0000819) (Diabetes mellitus) and [HP:0100732](http://purl.obolibrary.org/obo/HP_0100732) (Pancreatic fibrosis) 62.50%
- [HP:0025033](http://purl.obolibrary.org/obo/HP_0025033) (Abnormality of digestive system morphology) and [HP:0100651](http://purl.obolibrary.org/obo/HP_0100651) (Type I diabetes mellitus) and [HP:0100732](http://purl.obolibrary.org/obo/HP_0100732) (Pancreatic fibrosis) 62.50%
- [HP:0012718](http://purl.obolibrary.org/obo/HP_0012718) (Morphological abnormality of the gastrointestinal tract) and [HP:0100651](http://purl.obolibrary.org/obo/HP_0100651) (Type I diabetes mellitus) and [HP:0100732](http://purl.obolibrary.org/obo/HP_0100732) (Pancreatic fibrosis) 62.50%
- [HP:0011024](http://purl.obolibrary.org/obo/HP_0011024) (Abnormality of the gastrointestinal tract) and [HP:0100651](http://purl.obolibrary.org/obo/HP_0100651) (Type I diabetes mellitus) and [HP:0100732](http://purl.obolibrary.org/obo/HP_0100732) (Pancreatic fibrosis) 62.50%
- [HP:0004360](http://purl.obolibrary.org/obo/HP_0004360) (Abnormality of acid-base homeostasis) and [HP:0100651](http://purl.obolibrary.org/obo/HP_0100651) (Type I diabetes mellitus) and [HP:0100732](http://purl.obolibrary.org/obo/HP_0100732) (Pancreatic fibrosis) 62.50%


